HUS-yhtymae

Oncology and Hematologic Malignancies

HUS-yhtymae supports clinical research in breast cancer, colorectal cancer, rectal cancer, gastric cancer, pancreatic cancer, head and neck carcinoma, and broader advanced cancer care, with additional interest in myeloma multiplex and Monoclonal Gammopathy of Renal Significance.

  • Targeted anti-cancer therapies
  • Neoadjuvant and adjuvant cancer treatment
  • Minimal residual disease assessment
  • Early access to oncology medicines

Its oncology portfolio also includes treatment-related thromboprophylaxis, perioperative support, and evaluation of antineoplastic therapies across solid tumours and plasma cell disorders.

The sponsor funds studies in chronic subdural hematoma, delirium, acute neurological disease, neurodegenerative disease, neuropathic pain, and infantile spasm syndrome, alongside research on cerebral physiology and brain function.

  • Brain circulation and cerebrospinal fluid dynamics
  • Anticoagulation in neurosurgical patients
  • Sleep structure in pain disorders
  • Prevention of early-life epileptic syndromes

Research activity also extends to neurological outcomes linked with consciousness states, sedation, and recovery in complex brain-related conditions.

Surgery, Perioperative Care, and Transplantation

Clinical studies cover acute cholecystitis, hysterectomy, kidney transplantation, venous thromboembolism in surgical patients, and perioperative management in scoliosis surgery and other operative settings.

  • Infection prevention around surgery
  • Blood management and transfusion reduction
  • Graft function in transplantation
  • Thrombosis prevention in surgical care

Its surgical research also includes frostbite injury management and postoperative outcome optimisation across general, abdominal, gynecologic, and urologic procedures.

Ophthalmology, Endocrinology, and Reproductive Health

HUS-yhtymae is active in glaucoma research, polycystic ovary syndrome, and women’s health studies related to operative and metabolic care.

  • Glaucoma treatment strategies
  • Metabolic treatment in polycystic ovary syndrome
  • Perioperative care in gynecologic surgery
  • Hormonal and reproductive medicine

These studies reflect interest in both chronic outpatient management and procedure-related outcomes in endocrine and reproductive conditions.

Infectious Disease, Immunology, and Rare Benign Tumours

The sponsor also funds research in Clostridioides difficile, acute laryngitis, laryngeal leukoplakia, and Warthin’s tumor, together with vaccine-related immune response studies and antimicrobial evaluation.

  • Antimicrobial and prophylactic treatment
  • Vaccine immunogenicity
  • Benign head and neck tumour care
  • Upper airway inflammatory conditions

Additional interest is seen in healthy volunteers and healthy adults for translational studies supporting safety and immune response assessment.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Prevention of Infantile Spasms with Vigabatrin in High-Risk Children Under 1 Year Old: A Study for Patients with Tuberous Sclerosis or Large Vascular Brain Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland
  • Study of Drug Combination for Advanced Cancer Patients with Known Molecular Profile – FINPROVE Study

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Finland
  • Study on Human Plasma Protein vs. Crystalloid for Fluid Management in Children with Scoliosis Undergoing Spinal Fusion Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Finland
  • Study on Apixaban for Preventing Blood Clots in Patients Undergoing Abdominal, Gynecologic, and Urologic Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland
  • A study comparing azithromycin with cefuroxime versus cefuroxime alone for preventing infections in patients undergoing hysterectomy

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland
  • Apixaban for Preventing Blood Clots in Adults Receiving Neoadjuvant Therapy for Muscle‑Invasive Bladder Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland